Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,094 | -7,607 | -3,527 | -12,300 | -9,329 |
| Depreciation Amortization | 3 | 2 | 1 | 4 | 4 |
| Other Working Capital | 650 | 308 | 196 | 400 | 378 |
| Other Operating Activity | 629 | 618 | 150 | 763 | 560 |
| Operating Cash Flow | $-9,812 | $-6,679 | $-3,180 | $-11,133 | $-8,387 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -4 | -4 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-4 | $-4 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -270 | -158 | -158 | -391 | -290 |
| Common Stock Issued | 6,514 | 6,514 | 2,503 | 9,436 | 12,177 |
| Common Stock Repurchased | N/A | N/A | N/A | 2,758 | N/A |
| Other Financing Activity | -824 | -756 | -321 | -617 | -567 |
| Financing Cash Flow | $5,420 | $5,600 | $2,024 | $11,186 | $11,320 |
| Beginning Cash Position | 12,458 | 12,458 | 12,458 | 12,409 | 12,409 |
| End Cash Position | 8,066 | 11,379 | 11,302 | 12,458 | 15,338 |
| Net Cash Flow | $-4,392 | $-1,079 | $-1,156 | $49 | $2,929 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,812 | -6,679 | -3,180 | -11,133 | -8,387 |
| Capital Expenditure | N/A | N/A | N/A | -4 | -4 |
| Free Cash Flow | -9,812 | -6,679 | -3,180 | -11,137 | -8,391 |